Addex Therapeutics (ADXN) EBT (2022 - 2025)
Historic EBT for Addex Therapeutics (ADXN) over the last 4 years, with Q3 2025 value amounting to -$2.0 million.
- Addex Therapeutics' EBT fell 1182.67% to -$2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$7.3 million, marking a year-over-year decrease of 4026.93%. This contributed to the annual value of -$5.6 million for FY2024, which is 10046.34% down from last year.
- As of Q3 2025, Addex Therapeutics' EBT stood at -$2.0 million, which was down 1182.67% from -$2.4 million recorded in Q2 2025.
- Addex Therapeutics' 5-year EBT high stood at $6.6 million for Q4 2022, and its period low was -$7.5 million during Q2 2022.
- Its 4-year average for EBT is -$1.7 million, with a median of -$1.6 million in 2024.
- In the last 5 years, Addex Therapeutics' EBT skyrocketed by 9365.62% in 2023 and then crashed by 17779.3% in 2024.
- Over the past 4 years, Addex Therapeutics' EBT (Quarter) stood at $6.6 million in 2022, then crashed by 115.36% to -$1.0 million in 2023, then tumbled by 34.16% to -$1.4 million in 2024, then plummeted by 45.16% to -$2.0 million in 2025.
- Its EBT stands at -$2.0 million for Q3 2025, versus -$2.4 million for Q2 2025 and -$1.6 million for Q1 2025.